WithSecure Oyj
WithSecure Corporation: SHARE REPURCHASE 25.3.2025
WithSecure Corporation: SHARE REPURCHASE 25.3.2025
| WithSecure Corporation, STOCK EXCHANGE RELEASE, 25 March 2025 at 6.30 PM (EET) | ||
| WithSecure Corporation: SHARE REPURCHASE 25.3.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 25.3.2025 | |
| Bourse trade | Buy | |
| Share | WITH | |
| Amount | 15 000 | Shares |
| Average price/ share | 0,9588 | EUR |
| Total cost | 14 382,00 | EUR |
| WithSecure Corporation now holds a total of 256 890 shares | ||
| including the shares repurchased on 25.3.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Withsecure Corporation | ||
| Nordea Bank Oyj | ||
| Janne Sarvikivi | Sami Huttunen | |
| Contact information: | ||
| Laura Viita | ||
| Vice President Controlling, Investor relations and Sustainability | ||
| WithSecure Corporation | ||
| Tel. +358 50 4871044 | ||
| Investor-relations@withsecure.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
EDUBAND LLP27.3.2025 13:04:16 CET | Press release
Akademily (EDUBAND LLP) Launches New Service to Support Beginner Entrepreneurs with Business Plans
Brookfield Wealth Solutions27.3.2025 13:00:29 CET | Press release
Brookfield Wealth Solutions Completes Annual Filings
Evaxion Biotech27.3.2025 13:00:21 CET | Press release
Evaxion to announce business update and full year 2024 financial results on April 1, 2025
ZenaTech Inc.27.3.2025 13:00:00 CET | Press release
ZenaTech Signs LOI to Acquire Eighth Land Survey Company Advancing Drone as a Service in a $2.5 Billion US Drone Survey Market by 2033
Genmab A/S27.3.2025 13:00:00 CET | Press release
TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom